Parkinson's Disease Patients

Treatment responders with depression in Parkinson's disease demonstrated significant improvement on the HAM-D somatic subscale compared to nonresponders after 8 weeks of antidepressant treatment, incl

Effect: improvement; Cohen's d= 1.30

Treatment responders with depression in Parkinson's disease demonstrated significant improvement on the HAM-D somatic subscale compared to nonresponders after 8 weeks of antidepressant treatment, incl

Effect: improvement; Cohen's d= 1.30

Treatment responders with depression in Parkinson's disease demonstrated significant improvement on the HAM-D somatic subscale compared to nonresponders after 8 weeks of antidepressant treatment, incl

Effect: improvement; Cohen's d= 1.30

Treatment responders with depression in Parkinson's disease demonstrated significant improvement on the HAM-D somatic subscale compared to nonresponders after 8 weeks of antidepressant treatment, incl

Effect: improvement; Cohen's d= 1.30

Treatment responders with depression in Parkinson's disease demonstrated significant improvement on the HAM-D somatic subscale compared to nonresponders after 8 weeks of antidepressant treatment, incl

Effect: improvement; Cohen's d= 1.30

Treatment responders with depression in Parkinson's disease demonstrated significant improvement on the HAM-D somatic subscale compared to nonresponders after 8 weeks of antidepressant treatment, incl

Effect: improvement; Cohen's d= 1.30

Treatment responders with depression in Parkinson's disease demonstrated significant improvement on the HAM-D somatic subscale compared to nonresponders after 8 weeks of antidepressant treatment, incl

Effect: improvement; Cohen's d= 1.30

Treatment responders with depression in Parkinson's disease demonstrated significant improvement on the HAM-D somatic subscale compared to nonresponders after 8 weeks of antidepressant treatment, incl

Effect: improvement; Cohen's d= 1.30

Treatment responders with depression in Parkinson's disease demonstrated significant improvement on the HAM-D somatic subscale compared to nonresponders after 8 weeks of antidepressant treatment, incl

Effect: improvement; Cohen's d= 1.30

Treatment responders with depression in Parkinson's disease demonstrated significant improvement on the HAM-D somatic subscale compared to nonresponders after 8 weeks of antidepressant treatment, incl

Effect: improvement; Cohen's d= 1.30

Treatment responders with depression in Parkinson's disease demonstrated significant improvement on the HAM-D somatic subscale compared to nonresponders after 8 weeks of antidepressant treatment, incl

Effect: improvement; Cohen's d= 1.30

Treatment responders with depression in Parkinson's disease demonstrated significant improvement on the HAM-D somatic subscale compared to nonresponders after 8 weeks of antidepressant treatment, incl

Effect: improvement; Cohen's d= 1.30

Treatment responders with depression in Parkinson's disease demonstrated significant improvement on the HAM-D somatic subscale compared to nonresponders after 8 weeks of antidepressant treatment, incl

Effect: improvement; Cohen's d= 1.30

Treatment responders with depression in Parkinson's disease demonstrated significant improvement on the HAM-D somatic subscale compared to nonresponders after 8 weeks of antidepressant treatment, incl

Effect: improvement; Cohen's d= 1.30

Treatment responders with depression in Parkinson's disease demonstrated significant improvement on the HAM-D somatic subscale compared to nonresponders after 8 weeks of antidepressant treatment, incl

Effect: improvement; Cohen's d= 1.30

Treatment responders with depression in Parkinson's disease demonstrated significant improvement on the HAM-D somatic subscale compared to nonresponders after 8 weeks of antidepressant treatment, incl

Effect: improvement; Cohen's d= 1.30

Treatment responders with depression in Parkinson's disease demonstrated significant improvement on the HAM-D somatic subscale compared to nonresponders after 8 weeks of antidepressant treatment, incl

Effect: improvement; Cohen's d= 1.30

Treatment responders with depression in Parkinson's disease demonstrated significant improvement on the HAM-D somatic subscale compared to nonresponders after 8 weeks of antidepressant treatment, incl

Effect: improvement; Cohen's d= 1.30

Treatment responders with depression in Parkinson's disease demonstrated significant improvement on the HAM-D somatic subscale compared to nonresponders after 8 weeks of antidepressant treatment, incl

Effect: improvement; Cohen's d= 1.30

Treatment responders with depression in Parkinson's disease demonstrated significant improvement on the HAM-D somatic subscale compared to nonresponders after 8 weeks of antidepressant treatment, incl

Effect: improvement; Cohen's d= 1.30

Treatment responders with depression in Parkinson's disease demonstrated significant improvement on the HAM-D somatic subscale compared to nonresponders after 8 weeks of antidepressant treatment, incl

Effect: improvement; Cohen's d= 1.30

Treatment responders with depression in Parkinson's disease demonstrated significant improvement on the HAM-D somatic subscale compared to nonresponders after 8 weeks of antidepressant treatment, incl

Effect: improvement; Cohen's d= 1.30

Treatment responders with depression in Parkinson's disease demonstrated significant improvement on the HAM-D somatic subscale compared to nonresponders after 8 weeks of antidepressant treatment, incl

Effect: improvement; Cohen's d= 1.30

Treatment responders with depression in Parkinson's disease demonstrated significant improvement on the HAM-D somatic subscale compared to nonresponders after 8 weeks of antidepressant treatment, incl

Effect: improvement; Cohen's d= 1.30

Treatment responders with depression in Parkinson's disease demonstrated significant improvement on the HAM-D somatic subscale compared to nonresponders after 8 weeks of antidepressant treatment, incl

Effect: improvement; Cohen's d= 1.30

Treatment responders with depression in Parkinson's disease demonstrated significant improvement on the HAM-D somatic subscale compared to nonresponders after 8 weeks of antidepressant treatment, incl

Effect: improvement; Cohen's d= 1.30

Treatment responders with depression in Parkinson's disease demonstrated significant improvement on the HAM-D somatic subscale compared to nonresponders after 8 weeks of antidepressant treatment, incl

Effect: improvement; Cohen's d= 1.30